Ganga Pharmaceuticals Ltd.

BSE: 539680

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

12.50+0.0 (+0.00%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Ganga Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	Mar Sept	Mar Sept	Mar Sept	Mar Sept	Mar Sept	Mar Sept	Mar Sept	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	16May	—	—

Corporate Announcements and Regulatory Filings

Ganga Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
Change in Directorate26 Sept 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Managing Director
AGM26 Sept 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 37th Annual General Meeting along with the Scrutinizer Report
Closure of Trading Window26 Sept 2026
Closure of Trading Window
Closure of Trading Window
AGM26 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of the AGM held on Saturday, September 26, 2026
Newspaper Publication2 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication in connection with the 37th Annual General Meeting of the Company
General1 Sept 2026
The Company Has Sent Letter To The Shareholder For AGM Whose Email Id Is Not Registered With RTA.
The Company has sent Letter to the Shareholder for aGM whose Email Id is not resgistered with the RTA
AGM1 Sept 2026
Notice Of The AGM For F.Y. 2025-26
Please find enclosed herewith the Notice of the AGM for F.Y. 2025-26
Reg. 34 (1) Annual Report1 Sept 2026
Reg. 34 (1) Annual Report.
Please find enclosed herewith the Annual Report for F.Y. 2025-26
AGM1 Sept 2026
Intimation For 37Th Annual General Meeting Scheduled To Be Held On Saturday, September 26, 2026
Intimation for 37th Annual General Meeting Schedule to be held on Saturday, September 26, 2026
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended June 2026
Newspaper Publication9 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication regarding Special window for re-lodgement of transfer and dematerialisation request(s) of Physical securities
Reg.24(A)-Annual Secretarial Compliance28 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Non-Applicability of Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
General21 May 2026
Appointment Of Secretarial Auditor
Appointment of Secretarial Auditor
General21 May 2026
Appointment Of Internal Auditor
Appointment of Internal Auditor
Outcome of Board Meeting21 May 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 21, 2026
Outcome of the Board Meeting held on May 21, 2026
Board Meeting14 May 2026
Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
Closure of Trading Window26 Mar 2026
Closure of Trading Window
Intimation of Closure of Trading Window
Newspaper Publication16 Mar 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities

Frequently Asked Questions

Where can I download the annual report of Ganga Pharmaceuticals Ltd.?

Annual reports of Ganga Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Ganga Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Ganga Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Ganga Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Ganga Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Ganga Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Ganga Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Ganga Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Ganga Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Ganga Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Ganga Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Ganga Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Ganga Pharmaceuticals Ltd. is INE615T01017. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Ganga Pharmaceuticals Ltd. listed?

Ganga Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is GANGAPHARM and the BSE code is -.

Where can I find the shareholding pattern of Ganga Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Ganga Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Ganga Pharmaceuticals Ltd. on Sharpely?

Share price data for Ganga Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.